Zopiclone and Depakene drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zopiclone (eszopiclone) and Depakene (valproic acid). Common drug interactions include peritonitis among females and diabetes mellitus among males.
The phase IV clinical study analyzes what interactions people have when they take Zopiclone and Depakene. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.
What is Zopiclone?
Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 54,330 Zopiclone users. Check the latest studies of Zopiclone.
What is Depakene?
Depakene has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 14,776 Depakene users. Check the latest studies of Depakene.
28 people who take Zopiclone and Depakene together, and have interactions are studied.

What are the common drug interactions of Zopiclone and Depakene, by gender? *:
female:
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
- Pneumonia
- Pyrexia (fever)
- Renal failure acute (rapid kidney dysfunction)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Suicide attempt
- Thrombocytopenia (decrease of platelets in blood)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Tongue discolouration (colour change of tongue)
male:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Alanine aminotransferase increased
- Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Psychiatric symptom
- Abnormal sensation in eye
- Anxiety
- Beta-n-acetyl-d-glucosaminidase increased
- Blood lactate dehydrogenase increased
- Blood urea decreased
What are the common drug interactions of Zopiclone and Depakene, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Altered state of consciousness (altered state of mind)
- Asthenia (weakness)
- Sedation
- Coma (state of unconsciousness lasting more than six hours)
- Suicidal ideation
- Drug level above therapeutic
- Galactorrhoea (secretion of breast milk in men)
- Tardive dyskinesia (a disorder that involves involuntary movements)
- Weight increased
- Heart rate decreased
30-39:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood lactate dehydrogenase increased
- Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
- Gamma-glutamyltransferase increased
- Generalised erythema (redness of the skin all over the body)
- Human herpes virus 6 serology positive
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Lymphocyte count increased
- Lymphocyte stimulation test positive
40-49:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Psychiatric symptom
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Beta-n-acetyl-d-glucosaminidase increased
- Blood urea decreased
- Breath odour
- C-reactive protein increased
50-59:
- Cholecystitis (infection of gallbladder)
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Abnormal sensation in eye
- Anxiety
- Depression suicidal (suicide depressive disorder)
- Depressive symptom
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
60+:
- Coma (state of unconsciousness lasting more than six hours)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Pneumonia
- Purpura (purplish discoloration of the skin)
- Pyrexia (fever)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
What are the existing conditions these people have? *
- Depression: 5 people, 17.86%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 14.29%
- Bipolar Disorder (mood disorder): 4 people, 14.29%
- Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 2 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Zopiclone and Depakene?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Zopiclone and Depakene:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zopiclone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Depakene:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zopiclone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Depakene and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
- Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on eszopiclone and valproic acid (the active ingredients of Zopiclone and Depakene, respectively), and Zopiclone and Depakene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Digoxin and Bromhexine Hydrochloride - a second ago
- Could Azopt cause Anxiety Aggravated? - 4 seconds ago
- Drug interactions of Pantoprazole Sodium and Nucynta - 8 seconds ago
- Dehydration and White Blood Cell Count Decreased - 13 seconds ago
- Drug interactions of Avandia and Paclitaxel - 17 seconds ago
- Drug interactions of Detrol and Diflucan - 20 seconds ago
- Drug interactions of Bromfenac Sodium and Amaryl - 21 seconds ago
- Could Nasonex cause Ocular Hypertension? - 26 seconds ago
- Could Exondys 51 cause Stress And Anxiety? - 32 seconds ago
- Iron Overload and Neoplasm Progression - 32 seconds ago